Hu Rongyi相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Tumor-infiltrating CD4(+) CD25(+) FOXP3(+) Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma.

肿瘤浸润 CD4(+) CD25(+) FOXP3(+) Treg 与血浆 EBV DNA 和鼻咽癌的疾病进展相关

期刊:Infectious Agents and Cancer

影响因子:2.8

doi:10.1186/s13027-025-00660-4

Feng Enzi, Yang Yaoyu, Yang Jie, Hu Rongyi, Tian Ling, Yang Xinyu, Yang Meng, Qu Qianqian, Ren Yanxin, Li Xiaojiang

发表日期：2025

文献求助收藏

Evidence-based integration of clinicopathological factors with the risk of papillary thyroid carcinoma lateral cervical lymph node metastasis: systematic review and meta-analysis and subgroup study

基于循证医学的临床病理因素与乳头状甲状腺癌颈侧淋巴结转移风险的整合：系统评价、荟萃分析和亚组研究

期刊:Gland Surgery

影响因子:1.6

doi:10.21037/gs-2025-60

Hu, Rongyi; Ren, Qianlang; Li, Tiebin; Lv, Chunyan; Yang, Jie; Ren, Yanxin; Lin, Fusheng; Li, Xiaojiang

免疫/内分泌

发表日期：2025

文献求助收藏

A Randomized Controlled Trial for the Optimal Implementation of Psoriasis Treatment by Integrating Chinese and Western Medicine

一项关于中西医结合治疗银屑病最佳方案的随机对照试验

doi:10.2147/PTT.S487536

Yu, Yuanting; Sun, Xiaoying; Hu, Rongyi; Xia, Ping; Wei, Yuegang; Yang, Wenxin; Huang, Ning; Ding, Yangfeng; Guo, Shun; Yang, Chunyan; Weng, Huilan; Zhang, Ying; Ding, Xiaojie; Huang, Qinsi; Zhou, Xiaoyong; Li, Xin; Li, Bin

发表日期：2025

文献求助收藏

Our Choice: study protocol for a randomized controlled trial for optimal implementation of psoriasis treatment by the integration of Chinese and western medicine

我们的选择：一项随机对照试验的研究方案，旨在通过中西医结合优化银屑病治疗方案。

doi:10.1186/s13063-020-4209-3

Sun, Xiaoying; Zhou, Xiaoyong; Wei, Yuegang; Yang, Wenxin; Huang, Ning; Ding, Yangfeng; Hu, Rongyi; Guo, Shun; Yang, Chunyan; Weng, Huilan; Zhang, Ying; Chen, Xi; Ding, Xiaojie; Liu, Liu; Yin, Qingfeng; Wang, Ruiping; Li, Xin; Li, Bin

发表日期：2020

文献求助收藏